Phase I clinical trial of the HER-1 vaccine in patients with prostate tumors of epithelial origin. - EC FI HER-1 CPRC

Trial Profile

Phase I clinical trial of the HER-1 vaccine in patients with prostate tumors of epithelial origin. - EC FI HER-1 CPRC

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 13 Dec 2016

At a glance

  • Drugs HER-1 vaccine Center of Molecular Immunology (Primary)
  • Indications Prostatic intraepithelial neoplasia
  • Focus Adverse reactions
  • Acronyms EC FI HER-1 CPRC; HER-1 CPRC
  • Most Recent Events

    • 13 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top